This paper outlines the steps in developing and implementing process measures of quality. Developing a process measure includes defining the purpose of and audiences for the measures, choosing the clinical area to evaluate, organizing the assessment team, choosing the component of the process to measure, writing the indicator specifications, performing preliminary tests of feasibility, reliability and validity, and determining scoring and analytical specifications. Given the growing evidence in the literature regarding the impact of care, and an evolving understanding of how to develop and implement process of care measures as outlined here, the future should bring the development and implementation of quality indicators that are rigorously developed and that will provide insights into opportunities to improve the quality of care.
quality measurement effort including the intended audience will wish to consider not only the clinical rationale for or consumer of the information [11, 12] . For example, will collecting the data but also the economic rationale. This will the quality measure be used for local improvement efforts, necessitate knowledge of the costs of data collection and for benchmarking externally against other organizations, or potential cost savings from improving the aspect of care by an accreditation agency? One should explicitly state what being evaluated. Some users may be reluctant to measure these uses are and who will use the measure. The uses and aspects of care for which the cost of collecting the data audiences for the measure are important to define, as they exceeds the potential economic benefit from improvement will dictate the focus on particular clinical areas and elements of that process. Clinical audiences and public representatives of care, discussed more extensively below. For example, may be interested in quality improvement efforts even if they patients using quality measures to select a physician may be increase health care costs, but it will be difficult to obtain more interested in indicators of physicians' communication funding from provider organization administrators, purand interpersonal interactions than would a provider or-chasers, or care management organizations for efforts that ganization selecting a physician. Purchasers interested in increase costs because these individuals and organizations are choosing providers may be more interested in high cost held accountable for reducing health care expenses. clinical areas than would clinicians undertaking quality improvement efforts. Regardless of the goal, the consumers of the information must believe that the metric is valid and Organize the assessment team represents an important domain of quality.
Different audiences and uses also determine which unit of Once the purpose and use have been defined, and the clinical analysis is of interest. For example, in the US, the unit of area and process domain selected, one can assemble an analysis may include the patient, the individual doctor or appropriate assessment team and appropriate advisors for clinician, the office practice group, the larger provider orthe measurement or improvement effort. The team's advisors ganization such as the hospital or practice network, the health should include representatives of the desired audience for plan, the state, the region, or the nation. Various audiences, the measure, as well as the clinicians that will be evaluated such as patients, employers, accreditation agencies, provider and the administrators whose resources will be used. To organizations and clinicians are interested in different units ensure that valid content is included, clinical experts and of analysis for different purposes. For example, comparison representatives of national professional and specialty societies of a health care plan's performance with that of other plans should be represented. In addition, quality of care researchers may have no meaning to consumers who are choosing with training in epidemiology who know how to evaluate physicians within the same plan, nor to the health plan measurement reliability and validity should be included in choosing or evaluating its participating physicians. On the the assessment team. Process measures of health care quality other hand, such data at the health plan level will be critical will change regularly as scientists and clinicians develop better to a health plan for marketing or accreditation. As the treatment methods. Because intensive resources are required desired unit of analysis moves closer to individual doctors to maintain and update these measures, joint efforts by or clinicians, concern is raised regarding the adequacy of professional societies, provider organizations, and regulators sample size. Individuals may have too few patients with the or accreditors will lead to the most efficient use of resources. disease of interest to provide precise estimates of the quality When possible, an organization wishing to develop process measure.
indicators would use its own resources most efficiently if it teams with others that also require these measures, or uses measures that have been developed by national organizations
Choose the clinical area to evaluate such as, in the USA, the National Committee on Quality Assurance [15] , the Center for Medicare and Medicaid Services In choosing clinical areas to evaluate, several criteria must (CMS), formerly the Healthcare Financing Administration be considered (Table 1) . Firstly, the clinical problem under (HCFA) [16] , or the Institute for Healthcare Improvement study must be important to the intended audience for the (IHI) [17] . desired purpose. For example, clinicians, provider organizations, accreditation agencies, and purchasers of care are interested in clinical areas that have a significant impact Select the process domain or criterion on morbidity, mortality, and/or costs of care. In some cases, clinician or purchaser audiences may wish to focus on clinical Evaluating the quality of a process of care requires deareas that are highly important to patients. The clinical area termination of whether clinicians adhere to practices that are or process domain can be of local importance, for example, important to achieve the best outcomes for similar patients. a hospital may have a particular problem with care in a
The linkage of practice to outcomes must either have been particular unit, or a user may focus on a problem of national demonstrated scientifically or must be widely accepted by significance such as congestive heart failure, which has a peers. Process evaluation can be done by asking clinical large impact on a national population [13, 14] . Indicators are experts in the field to judge the care based on their own designed as a means to improve clinical, service, and economic performance. When selecting measures of quality, some users knowledge of the standard of care without delineating specific [18, In order to determine whether to measure a specific component of the care process, it is helpful to review the 19]. Such subjective evaluation may be helpful in areas such strength of scientific evidence that inclusion of this comas critical care where the patient's condition is too complex ponent in the process measure will affect outcomes, to to fit into a category for which a guideline exists. However, consider whether it can be influenced by clinicians or mandue to poor inter-rater reliability with implicit review, five to agers, whether it is feasible to measure this component, seven evaluators are generally required to get an average whether there are existing measurement methods for it with rating that has high reliability. In addition, this method demonstrated reliability and validity, and whether there is obscures feedback to providers about specific elements of demonstrated variability among clinicians in how or whether care that can be improved and puts the evaluation in a 'black it is performed. box'.
Explicit process review establishes criteria for specific Evaluate the strength of scientific evidence for practices that should be done for a carefully defined poputhe process criterion lation of patients, and determines in what proportion of patients this practice has been applied. Explicit review is The scientific evidence for the relationship of the chosen more useful to providers because it provides feedback about component of the process (what providers do) and outcome exactly what has or has not been done. In addition, once measures (what happens to patients) should be established explicit criteria have been developed or chosen by clinical by empirical data. Ideally, process components measured experts, an individual assessor without clinical training can would be those demonstrated to cause a higher probability reliably determine whether they have been met. In explicit of achieving the desired outcome [13, 20] . Once the link is quality review, inconsistency in opinions about which elements established, providers have confidence that improvement in of care are important is adjudicated using a group process a process will translate into improvement in an outcome. or consensus method to develop the criteria. Most of the Because evidence establishing these types of links is rare, following discussion focuses on choosing specific com-developers of process measures often use consensus among ponents and measures for explicit review, although some providers to establish the validity of process-based quality parts are applicable to implicit review measurement methods measures. The belief among providers that the process measures evaluate an important domain of quality of care is critical as well.
to engaging providers in an evaluation and improvement important may not yet have had much attention. For example, process. Most non-clinical audiences for quality measures will in the area of diabetes, the American Diabetes Association be satisfied that a component of the process and the specific has developed guidelines for care. Some of the process method used to measure it are important for patient outcomes components specified in these guidelines have had extensive if providers with clinical expertise in the area agree that the measure development. For example, for evaluation of glycomponent and the method are important and if clinical cosylated hemoglobin and referral for retinal screening, the researchers with knowledge of the area confirm that the Center for Medicare and Medicaid Services [16] and the evidence supports their use.
National Committee on Quality Assurance [15] developed In considering the strength of the evidence for a particular precisely defined and specified indicators that have been explicit criterion, the assessment team should consider the widely applied and reported [27] . In the case of other aspects type and number of studies that are related to the indicator. of the process of care that may be demonstrated to be equally Randomized clinical trials provide the strongest evidence, or even more important to patient outcomes, such as whether while observational studies and reports of consensus groups or not dietary counseling has been provided, the measurement provide significantly weaker evidence [21] . Multiple studies methods may not have had such thorough testing. If an or meta-analyses of a topic provide stronger evidence than organization lacks extensive resources for measure desingle studies. The compendium Clinical Evidence [22] and velopment and testing, it may be worthwhile to choose a the Cochrane Collaboration website [23] are good resources process area for which measures and data collection methods for determining the strength of evidence available for various that have been demonstrated to be reliable and valid already elements of the process of health care. The strength of the exist. evidence for an indicator will determine its scientific soundness or the likelihood that improvement in the quality in-Decide if providers and managers can influence dicator will produce consistent and credible improvements the process component in quality of care.
For a measure of the process of care to be helpful in One widely used method for developing or choosing quality improvement, providers or managers must be able to criteria for explicit review of the process of care is the RAND influence that process. The sixth criterion in selecting clinical areas to evaluate is valid method to evaluate quality for other types of patients whether there is reason to believe that variability or suband medical conditions where there is little evidence from standard quality exists in that aspect of the process. The randomized clinical trials from which to create guidelines.
variability and substandard quality, usually unintended, represent the potential opportunity for quality improvement [12, Determine if the component of process is feasible 13] . This criterion is particularly important for internal quality to measure improvement efforts. Regulators and accreditors may use An important criterion for choosing the component of the minimal standards upon which there is nearly uniform good process is that it must be feasible to measure. For example, performance, although the trend in these organizations is measuring the use of barrier precautions while inserting to provide a multi-level evaluation that highlights excellent central venous catheters requires direct observation, and the performance as well as merely meeting minimal standards. resources for such observation may not be available. On the other hand, the frequency of prescription of beta-blockers for patients with myocardial infarction may be determined Write the measure specifications very easily if there is a computerized order entry system that allows flexible search inquiries.
After the quality measure or component of the process has been selected, the specifications for that measure must be Determine if there are existing measures that are stated. These specifications are the methods by which the reliable and valid target population is identified and the data are actually collected and should be developed with the same scientific rigor Measures may already have been developed for certain aspects of the clinical process, whereas others that may be equally with which we would develop research samples and data collection instruments. There are six steps in defining the Define the risk-adjustment strategy measure specifications.
Risk adjustment plays a smaller role when the indicator is a process measure than when it is an outcome measure. HowSelect the unit of analysis ever, for certain measures of process, risk adjustment may reveal that patient factors are influencing a measure and that The quality assessment team must specify the unit of analysis the measure does not actually reflect the process accurately. for the measure of process. As discussed earlier, this often For example, use of inhaled corticosteroids by asthma patients stems from identifying the desired purpose and audience for might be most easily measured by prescriptions filled, assessed the measure. For example, for US inpatient care, one must from pharmacy data. However, as described earlier, most specify whether the unit of analysis is the patient, the provider, clinicians, rather than learning what their patients took comthe provider group, the hospital service or unit, the hospital, pared with other clinicians' patients, would rather know what the health system, or the insurer. Explicitly stating the unit they prescribed as compared with other clinicians. This of analysis will help with interpretation of the measure. If evaluation might require more expensive medical record multiple measures are used, it is helpful to choose a common review rather than the proxy indicator obtained from pharunit of analysis. The choice of the unit of analysis may macy data. Such proxy indicators of the process of care may depend on other factors such as the purpose of the measure be more informative if presented with risk adjustment. For and the audience as has been described earlier.
example, prescriptions filled for inhaled steroids could be presented for different types of patients such as low-income Define the indicator patients or those with fewer years of education, or adjustedThe quality assessment team must define the indicator to be use rates could be developed using a model with many measured. For dichotomous measures (where the answer is patient characteristics. The more closely an indicator measures either 'yes' or 'no'), this is presented as a proportion of a the actual process of care delivered rather than patient population where a numerator and a denominator are defined, adherence or other factors, the less risk adjustment will be for example, the proportion of patients staying at least 24 needed. hours in the intensive care unit who received stress ulcer prophylaxis [28] .
Other measures may be continuous measures
Identify data sources and data collection that can be averaged, such as time to an event. Examples of procedures such indicators include time to antibiotic administration for patients presenting to an emergency department for com-Once all the required data are known, the assessment team munity-acquired pneumonia, or minutes to thrombolytic ther-must state where and how the data will be obtained [29] . apy for patients presenting to hospitals with myocardial There are four likely sources of data: existing administrative infarction or stroke. Alternatively, an indicator may be a rate, databases, existing medical records, clinical data collected defined as a proportion within a given time frame, such as prospectively for quality assessment purposes, and survey the proportion of patients for whom restraints were used in data collected prospectively. Each data source has its lima 24-hour period. Still other measures may be scores on a itations and benefits ( Table 2) . Regardless of the audience scale such as a pain or patient satisfaction scale.
and use for the data, it is most desirable to incorporate data collection into routine patient care, that is, to standardize Identify the intended sample and exclusions clinicians' and administrators' documentation of needed information about patient characteristics and care delivery that The intended sample is the group in whom the measure will is already being recorded for clinical purposes. Such a strategy be assessed who represent the population at risk. Developers will reduce missing data, will reduce the additional cost of of a measure must decide upon the inclusion criteria, exclusion data collection, and will educate clinicians about important criteria, and must choose prevalent (existing) versus incident elements of the process of care. If it eliminates other clinician (new) cases. Explicit selection criteria reduce potential data collection rather than being duplicative, this data colmeasurement bias. For example, if a quality measure is the lection strategy will increase clinician commitment to quality percent of intensive care unit patients who receive stress assessment and improvement initiatives. As electronic medical ulcer prophylaxis, the assessor must define the denominator records become more widespread, standard data spefor this rate. This denominator may include patients who are cifications useful for quality assessment can be incorporated mechanically ventilated, older patients, patients with raised into these systems. Making sure that routinely collected intracranial pressure, or patients who are in intensive care administrative and clinical data meet such specifications for more than 24 hours. For the use of inhaled corticosteroids has the potential to provide data for quality assessment in patients with asthma, patients included should clearly while streamlining clinical data collection rather than creating require the use of this medication. National guidelines state additional duplicative data collection efforts. The ability to that patients who have a severity level of moderate persistent achieve efficient data collection integrated with the clinical asthma, for example, should be using inhaled corticosteroids.
and administrative health care routine poses the single Identifying such patients, however, could require data colmost important consideration affecting the data collection lection of symptoms or physiology from patients or from the medical records. strategy. Produce data collection specifications modification. For example, the measure specifications may need to be more detailed, or the data to obtain the measure Detailed and explicit data specifications ensure quality control may not be available. Pilot testing can generally be performed of data collection and reduce the risk of error and bias. The on a small sample. Nonetheless, skipping this step is perilous. team should define explicitly both the population at risk and
As an example, a common process measure for congestive the method for evaluating patients' exposure to the specific heart failure is whether left ventricular function has been element of the process that represents the quality indicator.
assessed. In the USA, this assessment is often performed by For example, for prophylaxis for deep venous thrombosis, an outpatient physician and transmitted to an attending we would need to define high quality as any treatment physician in the hospital, and therefore is often missing from provided, or treatment above a specified threshold. To define the inpatient medical record. Pilot testing can identify that a a high-quality process of care to which the patient might or review of hospital records alone cannot be used as the data might not be exposed, issues arise similar to those encountered source for this process indicator. when evaluating exposure to a risk factor in a cohort study [30] . Without the same methodological rigor as would be Test the scientific strength of the measure applied in that situation, it will be difficult to determine whether the differences between groups as measured by a The next step in developing a quality measure is testing the quality indicator are true differences in quality or merely scientific strength of the measure, i.e. evaluating its reliability differences in data collection methods. After the specifications and validity. Reliability can be thought of as reproducibility: are written, pilot tests of the measure ensure that the data if I repeat the measure, will I obtain the same result? Reliability collection is feasible and accurate.
is important when comparing the quality indicator among If the assessment team uses a sampling strategy, such as groups and within groups over time. The commonly used random or systematic sampling, the sample size and power measures of reliability include inter-rater reliability (comparing calculations require justification [25, 26] . In addition to a differences among evaluators), internal consistency (comsampling strategy, the specifications should describe the time paring variation among items that should provide similar interval in which the data are to be collected, how patients results), and test-retest reliability (comparing differences when who are 'censored' (for example, those who die, or are the same person repeats the measure at two different time transferred to other services or locations) will be handled, points). and, when applicable, which of the multiple measures obtained
In process measurement, one can test inter-rater reliability, on a single patient will be included. Finally, the specifications test-retest reliability and internal consistency in order to need to include some method for data quality control.
determine whether selection and training of data abstractors, interviewers, or programmers, the indicator definition, and the data collection methods are precise enough to provide
Preliminary testing
reproducible results. For example, if a measure is well specified, and data collectors receive good training, different Pilot testing the measure and the data collection data collectors should come up with the same results and method there should be good inter-rater reliability. In addition, if the measure and data collection procedures are well specified, Although the design specifications are explicit, pilot testing the quality measure generally identifies areas requiring further the same data abstractor should come up with the same results on two different occasions when presented with the an evaluation of the distribution of the data, how missing same data, defined as good test-retest reliability. Finally, data are handled, a description of the unit of analysis, a internal consistency testing can also provide a check on the description of the comparison group, and the statistical reliability of the overall method when there are two or more analyses and tests to be used. It is important for the inrelated items. For example, one would hypothesize that if vestigators to consider what would be clinically significant appropriately defined, certain sub-indicators would be related differences in quality among groups rather than simply statto each other. If data collection methods are reliable, then, istically significant. for example, the proportion of patients who have orders for
One of the considerations in choosing the statistical test hemoglobin A1C testing should be equal to or greater than is the interpretation of the test results. Even if the measure the proportion of patients for whom a result of glycosylated is scientifically strong, it must be possible for the audience hemoglobin testing is present in the medical record or the for whom it is intended to interpret it. As a result, the way information system, and there should be a good correlation the measure is presented may vary by the audience. Pilot between scores on these two items.
testing is often required to ensure that the desired audience Validity is the extent to which the measure accurately is interpreting the measure appropriately. Data must be evaluates the domain of quality being assessed. The reliability presented in a meaningful way and efforts should be taken of a measure is necessary but not sufficient for validity; that to focus on efficient communication of information. If the is, a measure can be consistent but there may be other reasons audience for the measures consists of purchasers or patients why it is not valid. Validity can be tested by: (1) confirming who seek the information for health care purchasing decisions, that scores on the measure are linked to measures of important analysis plans that include summary variables or aggregations outcomes; (2) demonstrating that the scores that are obtained of individual process measures may be more helpful than the from using the measure are able to differentiate between individual process measures. Comparing levels of statistical good and bad quality assessed using another previously significance between groups becomes increasingly important; validated method known to be related to important outcomes; patients and enrollees want to know 'which is better.' Further or (3) evaluating whether the measure represents the process research is needed to design and present quality measures domain of interest as judged by the audience of users [14, that will enable patients to make informed decisions regarding 19] . quality of care.
Write specifications for scoring and Summary analysis
In this paper, we have outlined how to develop or choose Define acceptable performance and scoring explicit process indicators. Process measures are highly acceptable to providers because they demonstrate clearly how To determine what is acceptable performance, the assessment providers can improve their outcomes. Clinicians are also team must develop a protocol for scoring the measure [19] . more accountable for the process of care than outcomes, With some dichotomous variables, the raw data are sufficient.
which are affected by many other factors. As electronic For example, for process errors that always represent poor medical records become more common, process measures quality care, such as administering the wrong dose of a can be unobtrusively tracked as part of routine clinical care, medication, the proportion of patients experiencing the event which will aid in their implementation. Process measures that is a sufficient specification. Ordinal, or continuous data are incorporated into routine clinical data collection provide such as 'time-to-events' or rates may be converted into a constant educational reminder to clinicians about the correct dichotomous variables by specifying the proportion of process, and eliminate duplicative data collection for quality patients above a particular threshold. To aid in their inassessment. On the other hand, implementing process measterpretation, continuous variables can also be presented as ures can be difficult because they require constant updating means for a population in a comparison with a standard or as the science of medicine advances. Joint efforts among benchmarks. For survey data, specifications and rationale for providers, professional societies, and external government or converting item responses into scale scores must be included.
payer agencies to develop and maintain process measures The specifications must also include a plan for handling have made them more feasible. To be valid, process measures missing data or data that are outside of a logical range. All should have links to important outcomes, or should at least of the stakeholders involved in developing the quality measure be determined by consensus methods and be judged by should agree on what constitutes acceptable performance.
clinical experts to be important to patient outcomes. The past decade has brought a greater emphasis on synthesizing Develop the analytical plan the evidence basis for how process of care affects outcomes and has made this information more easily available to the The specifications must include a detailed plan for how the provider community as well as to the public. In the future measure is to be analyzed and how statistical and clinical this will provide the ultimate base for the development of significance will be determined. Part of determining the analytical plan must include a description of the population, process measures of quality.
